Best Endovascular versus Best Surgical Therapy in Patients with CLI (BEST-CLI) Trial: A Misleading Trial Name
- PMID: 36639118
- PMCID: PMC11524529
- DOI: 10.1016/j.jvir.2023.01.005
Best Endovascular versus Best Surgical Therapy in Patients with CLI (BEST-CLI) Trial: A Misleading Trial Name
Comment on
-
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.N Engl J Med. 2022 Dec 22;387(25):2305-2316. doi: 10.1056/NEJMoa2207899. Epub 2022 Nov 7. N Engl J Med. 2022. PMID: 36342173 Clinical Trial.
References
-
- Farber A, Menard MT, Conte MS, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med 2022; 387:2305–2316. - PubMed
-
- Iida O, Takahara M, Soga Y, et al. Three-year outcomes of surgical versus endovascular revascularization for critical limb ischemia: the SPINACH study (surgical reconstruction versus peripheral intervention in patients with critical limb ischemia). Circ Cardiovasc Interv 2017; 10:e005531. - PMC - PubMed
-
- Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366:1925–1934. - PubMed
-
- Siracuse JJ, Menard MT, Eslami MH, et al. Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative. J Vasc Surg 2016; 63:958–965.e1. - PubMed
-
- Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2018; 7:e011245. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous